Hardy Diagnostics has launched a multiplex immunoassay for detecting the five most common carbapenemase enzymes produced by Enterobacteriaceae and Pseudomonas aeruginosa from bacterial cultures through a distribution deal with the assay's manufacturer, NG Biotech.
Image courtesy of Hardy Diagnostics.NG-Test Carba 5 is designed to detect the following:
- Klebsiella pneumoniae carbapenemase (KPC)
- Oxacillinase (OXA)-48-like
- Verona integron-encoded metallo-beta-lactamase (VIM)
- Imipenemase (IMP)
- New Delhi metallo-beta-lactamase (NDM)
The companies said the test is more efficient than molecular methods, with results about resistance in 15 minutes.
